FDA Orange Book · active-ingredient family
Magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium acetate; sodium chloride; sodium gluconate; sodium phosphate, dibasic, heptahydrate
Magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium acetate; sodium chloride; sodium gluconate; sodium phosphate, dibasic, heptahydrate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ISOLYTE S PH 7.4 IN PLASTIC CONTAINER · NDA 019696
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ISOLYTE S PH 7.4 IN PLASTIC CONTAINERRLD | B BRAUN | NDA 019696 | — | Sep 29, 1989 | |
| ISOLYTE S PH 7.4 IN PLASTIC CONTAINER | B BRAUN | NDA 019006 | — | Apr 04, 1984 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium acetate; sodium chloride; sodium gluconate; sodium phosphate, dibasic, heptahydrate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
